Auxological and metabolic effects of long-term treatment with recombinant growth hormone in children born small for gestational age: a retrospective study-Reference-Cited by-同舟云学术

Auxological and metabolic effects of long-term treatment with recombinant growth hormone in children born small for gestational age: a retrospective study

Published:2024-01-12 Issue:1 Volume:84 Page:213-222
ISSN:1559-0100
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Ferrigno Rosario^ORCID,Savanelli Maria Cristina,Cioffi Daniela,Pellino Valeria,Klain Antonella

Funder

Pfizer

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12020-023-03665-4.pdf

Reference24 articles.

1. P.A. Lee, S.D. Chernausek, A.C. Hokken-Koelega et al. International small for gestational age advisory board consensus development conference statement: management of short children born small for gestational age, April 24–October 1, 2001. Pediatrics 111, 1253–1261 (2003)

2. M.J.J. Finken, M. van der Steen, C.C.J. Smeets et al. Children born small for gestational age: differential diagnosis, molecular genetic evaluation, and implications. Endocr. Rev. 39, 851–894 (2018).

3. M. de Jong, A. Cranendonk, M.M. van Weissenbruch, Components of the metabolic syndrome in early childhood in very-low-birth-weight infants and term small and appropriate for gestational age infants. Pediatr. Res. 78, 457–461 (2015)

4. N.J. Arends, V.H. Boonstra, H.J. Duivenvoorden et al. Reduced insulin sensitivity and the presence of cardiovascular risk factors in short prepubertal children born small for gestational age (SGA). Clin. Endocrinol. 62, 44–50 (2005)

5. P.E. Clayton, S. Cianfarani, P. Czernichow et al. Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society. J. Clin. Endocrinol. Metab. 92, 804–810 (2007)